Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 688-698

  Park, Kyoungmin ^a   Jin, Ji ^b   Hu, Yang ^a   Zhou, Kevin ^a   Ma, Jian Xing ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; OCCLUDIN; PIGMENT EPITHELIUM DERIVED FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EYE PROTECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LASER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETINA NEOVASCULARIZATION; RETINITIS; RETINOPATHY; SUBRETINAL NEOVASCULARIZATION; TRANSGENIC MOUSE; VISION;

EID: 79951833044     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.014     Document Type: Article

References (69)

1. Becerra SP, Sagasti A, Spinella P, Notario V: Pigment epithelium-derived factor behaves like a noninhibitory serpin: neurotrophic activity does not require the serpin reactive loop. J Biol Chem 1995, 270:25992-25999
2. Steele FR, Chader GJ, Johnson LV, Tombran-Tink J: Pigment epithelium- derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A 1993, 90:1526-1530 (Pubitemid 23058206)
3. Becerra SP, Palmer I, Kumar A, Steele F, Shiloach J, Notario V, Chader GJ: Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli: a functionally active neurotrophic factor. J Biol Chem 1993, 268:23148-23156 (Pubitemid 23328026)
4. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285:245-248 (Pubitemid 29329995)
5. King GL, Suzuma K: Pigment-epithelium-derived factor-a key coordinator of retinal neuronal and vascular functions. N Engl J Med 2000, 342:349-351 (Pubitemid 30075252)
6. Amaral J, Fariss RN, Campos MM, Robison WG Jr, Kim H, Lutz R, Becerra SP: Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery. Invest Ophthalmol Vis Sci 2005, 46:4383-4392 (Pubitemid 44264530)
7. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX: Pigment epithelium- derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006, 20:323-325 (Pubitemid 46671158)
8. Matsuoka M, Ogata N, Otsuji T, Nishimura T, Takahashi K, Matsumura M: Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 2004, 88:809-815 (Pubitemid 38725593)
9. Filleur S, Nelius T, de Riese W, Kennedy RC: Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem 2009, 106:769-775
10. Yang H, Grossniklaus HE: Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. Invest Ophthalmol Vis Sci 2010, 51:28-34
11. Spranger J, Osterhoff M, Reimann M, Mohlig M, Ristow M, Francis MK, Cristofalo V, Hammes HP, Smith G, Boulton M, Pfeiffer AF: Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 2001, 50:2641-2645 (Pubitemid 33733112)
12. Holekamp NM, Bouck N, Volpert O: Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 2002, 134:220-227 (Pubitemid 34831826)
13. Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M: Decrease of pigment epithelium-derived factor in aqueous humor with increasing age. Am J Ophthalmol 2004, 137:935-936 (Pubitemid 38582050)
14. Clements RS Jr, Robison WG Jr, Cohen MP: Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 1998, 12:28-33
15. Cohen MP, Hud E, Shea E, Shearman CW: Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy. Ophthalmic Res 2008, 40:5-9 (Pubitemid 350308296)
16. Notari L, Miller A, Martinez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP: Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 2005, 46:2736-2747 (Pubitemid 43086693)
17. Mori K, Gehlbach P, Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA: AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2002, 43:1994-2000 (Pubitemid 34587052)
18. Stellmach V, Crawford SE, Zhou W, Bouck N: Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 2001, 98:2593-2597 (Pubitemid 32209527)
19. Raisler BJ, Berns KI, Grant MB, Beliaev D, Hauswirth WW: Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proc Natl Acad Sci U S A 2002, 99:8909-8914 (Pubitemid 34693657)
20. Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA: Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2002, 43:2428-2434 (Pubitemid 34700678)
21. Huang Q, Wang S, Sorenson CM, Sheibani N: PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res 2008, 87:226-241
22. Park K, Chen Y, Hu Y, Mayo AS, Kompella UB, Longeras R, Ma JX: Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes- induced retinal vascular leakage. Diabetes 2009, 58:1902-1913
23. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111 (Pubitemid 24046832)
24. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA: Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998, 153:1641-1646 (Pubitemid 28509922)
25. Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA: Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 2001, 188:253-263 (Pubitemid 32622916)
26. Kachi S, Esumi N, Zack DJ, Campochiaro PA: Sustained expression after nonviral ocular gene transfer using mammalian promoters. Gene Ther 2006, 13:798-804
27. Hong DH, Pawlyk BS, Adamian M, Sandberg MA, Li T: A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo. Invest Ophthalmol Vis Sci 2005, 46:435-441 (Pubitemid 40270319)
28. Chen J, Connor KM, Aderman CM, Smith LE: Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008, 118:526-533 (Pubitemid 351206543)
29. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE: Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 2009, 4:1565-1573
30. Smith LE: Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 2002, 91:26-28
31. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E: Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996, 80:241-245
32. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995, 92:905-909
33. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994, 145:574-584 (Pubitemid 24285965)
34. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, Inomata H: Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 1997, 235:159-167 (Pubitemid 27129479)
35. Kwak N, Okamoto N, Wood JM, Campochiaro PA: VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2000, 41:3158-3164
36. Hangai M, He S, Hoffmann S, Lim JI, Ryan SJ, Hinton DR: Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells. J Neuroimmunol 2006, 171:45-56 (Pubitemid 41832277)
37. Bian ZM, Elner SG, Elner VM: Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res 2007, 84:812-822 (Pubitemid 46590123)
38. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ, Ambati BK: An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 2003, 9:1390-1397 (Pubitemid 37466188)
39. Yamada K, Sakurai E, Itaya M, Yamasaki S, Ogura Y: Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci 2007, 48:1839-1843 (Pubitemid 351261373)
40. Watanabe D, Takagi H, Suzuma K, Oh H, Ohashi H, Honda Y: Expression of connective tissue growth factor and its potential role in choroidal neovascularization. Retina 2005, 25:911-918 (Pubitemid 41456584)
41. Regatieri CV, Dreyfuss JL, Melo GB, Lavinsky D, Farah ME, Nader HB: Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated glycosaminoglycans. Invest Ophthalmol Vis Sci 2009, 50:5487-5494
42. Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H, Hori S: Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2006, 113:294-301 (Pubitemid 43170779)
43. Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA: Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 2006, 82:99-110 (Pubitemid 43063401)
44. Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU: Clinical protocol: an open-label, phase I, single administration, dose-escalation study of ADGVPEDF 11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther 2001, 12:2029-2032
45. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ: Pigment epithelium- derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 2002, 43:821-829 (Pubitemid 34184503)
46. Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M: Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001, 189:323-333 (Pubitemid 33063300)
47. Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J: Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 2001, 489:270-276 (Pubitemid 32126422)
48. Dot C, Parier V, Behar-Cohen F, Benezra D, Jonet L, Goldenberg B, Picard E, Camelo S, de Kozak Y, May F, Soubrane G, Jeanny JC: Influence of age on retinochoroidal healing processes after argon photocoagulation in C57bl/6j mice. Mol Vis 2009, 15:670-684
49. Kent D, Sheridan C: Choroidal neovascularization: a wound healing perspective. Mol Vis 2003, 9:747-755 (Pubitemid 38097640)
50. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M: Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002, 43:1168-1175 (Pubitemid 34258289)
51. Gehlbach P, Demetriades AM, Yamamoto S, Deering T, Duh EJ, Yang HS, Cingolani C, Lai H, Wei L, Campochiaro PA: Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther 2003, 10:637-646 (Pubitemid 36553609)
52. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA: Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997, 151:281-291
53. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487 (Pubitemid 24356306)
54. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE: Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002, 25:2328-2334
55. Pelzek C, Lim JI: Diabetic macular edema: review and update. Ophthalmol Clin North Am 2002, 15:555-563 (Pubitemid 36076610)
56. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M: Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002, 134:348-353
57. Boehm BO, Lang G, Feldmann B, Kurkhaus A, Rosinger S, Volpert O, Lang GK, Bouck N: Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. A pilot study. Horm Metab Res 2003, 35:382-386 (Pubitemid 37102685)
58. Aiello LP: Angiogenic pathways in diabetic retinopathy. N Engl J Med 2005, 353:839-841
59. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 1998, 21:143-156 (Pubitemid 28030402)
60. Shestakova MV, Kochemasova TV, Gorelysheva VA, Osipova TV, Polosukhina EP, Baryshnikov A, Dedov II: [The role of adhesion molecules (ICAM-1 and E-selectin) in development of diabetic microangiopathies]. Ter Arkh 2002, 74:24-27
61. Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt- Rasmussen B: Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med 2000, 17:644-649
62. Ueda S, Yamagishi SI, Okuda S: Anti-vasopermeability effects of PEDF in retinal-renal disorders. Curr Mol Med 10:279-283
63. Cai J, Jiang WG, Grant MB, Boulton M: Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 2006, 281:3604-3613 (Pubitemid 43845978)
64. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX: Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 2006, 37:1-12 (Pubitemid 44288601)
65. Pulkkinen K, Murugan S, Vainio S: Wnt signaling in kidney development and disease. Organogenesis 2008, 4:55-59 (Pubitemid 351881300)
66. Chen Y, Hu Y, Lu K, Flannery JG, Ma JX: Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem 2007, 282: 34420-34428 (Pubitemid 350159486)
67. Chen Y, Hu Y, Zhou T, Zhou KK, Mott R, Wu M, Boulton M, Lyons TJ, Gao G, Ma JX: Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 2009, 175:2676-2685
68. Zhang B, Zhou KK, Ma JX: Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes 59:1809-1816
69. Zhou T, Hu Y, Chen Y, Zhou K, Zhang B, Gao G, Ma JX: The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest Ophthalmol Vis Sci 2010, 51:4371-4379